Doxycycline for rosacea

Efracea (doxycycline) is a new oral treatment for facial rosacea in patients aged 12 years and over. The recommended dose of the product is one 40mg modified-release capsule once daily.

View Efracea drug record

Further information: Galderma

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

'Life-changing' migraine drug approved by NICE

'Life-changing' migraine drug approved by NICE

The decision by NICE means patients with chronic migraine...

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Treatment with a four-drug regimen incorporating newer...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...